Analysis on clinical effect of three types of uterine contraction inhibitors to treat threatened premature delivery

Qi-yun LUO,Shun-hao MENG,Sui-wen YE,Shuai FU,Qing-lin LONG,Hui CHEN
2012-01-01
Abstract:Objective To investigate the clinical effects of 3 types of uterine contractions inhibitors,ritodrine,atosiban and magnesium sulfate,to treat threatened premature delivery.Methods 100 pregnant women with threatened premature delivery were randomly divided into 3 groups,ritodrine group(40 cases),atosiban group(30 cases) and magnesium sulfate group(30 cases).The time-to-effect,success rate of fetus protection and the adverse reactions after medication were observed among 3 groups.Results The ritodrine group and the atosiban group showed no statistical difference by comparison with each other in the aspects of the time-to-effect,success rate of fetus protection,prolonged pregnancy duration,full-term delivery rate and neonatal weight(P>0.05).But the two groups were significantly better than the magnesium sulfate group with statistical difference(P<0.05).There were no statistical differences in the incidence rate of adverse reactions among 3 groups.Conclusion Ritodrine,atosiban and magnesium sulfate all can effectively restrain uterine contractions with safe medication.For the treatment of threatened premature labor,ritodrine and atosiban are superior to magnesium sulfate.These 2 drugs have similar effects,but ritodrine can be used as the first choice to treat threatened premature delivery due to its lower cost.
What problem does this paper attempt to address?